NewsRx

Search our medical news database

Collaborations

Ortec to collaborate to facilitate stem-cell therapy development

Published in Medical Letter on the CDC and FDA, May 30th, 2004

Ortec International, Inc., (ORTN) and ES Cell International Pte, Ltd., (ESI) announced an agreement to collaborate in the development of ESI's human Embryonic Stem Cell (hES) -derived cell-therapy products.

Under the terms of the agreement, Ortec will supply ESI with human skin cells generated from cell lines developed and manufactured by Ortec for use in its tissue engineered product, OrCel. The cells to be provided have undergone extensive testing for viruses in accordance with current U.S. Food and Drug Administration (FDA) guidelines and are expected to be used by ESI in research and development and in commercialization of their stem-cell products.

...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook